nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MPO—Carboplatin—bone cancer	0.262	0.394	CbGbCtD
Melatonin—MPO—Cisplatin—bone cancer	0.224	0.337	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—bone cancer	0.0998	0.15	CbGbCtD
Melatonin—SLC22A8—Methotrexate—bone cancer	0.0534	0.0802	CbGbCtD
Melatonin—CYP2C9—Cisplatin—bone cancer	0.0263	0.0395	CbGbCtD
Melatonin—CALM1—trigeminal nerve—bone cancer	0.0029	0.113	CbGeAlD
Melatonin—ESR1—periosteum—bone cancer	0.00247	0.0962	CbGeAlD
Melatonin—IDO1—connective tissue—bone cancer	0.00238	0.0928	CbGeAlD
Melatonin—EPX—bone marrow—bone cancer	0.00209	0.0815	CbGeAlD
Melatonin—CALM1—cranial nerve—bone cancer	0.00206	0.0804	CbGeAlD
Melatonin—Nabumetone—PTGS2—bone cancer	0.00152	0.624	CrCbGaD
Melatonin—CALR—connective tissue—bone cancer	0.0014	0.0544	CbGeAlD
Melatonin—MT3—spinal cord—bone cancer	0.00117	0.0457	CbGeAlD
Melatonin—CALR—tendon—bone cancer	0.00096	0.0374	CbGeAlD
Melatonin—CALR—bone marrow—bone cancer	0.00093	0.0362	CbGeAlD
Melatonin—CALR—spinal cord—bone cancer	0.000926	0.0361	CbGeAlD
Melatonin—Almotriptan—CYP3A4—bone cancer	0.000916	0.376	CrCbGaD
Melatonin—Abdominal discomfort—Cisplatin—bone cancer	0.000676	0.00715	CcSEcCtD
Melatonin—Glycosuria—Doxorubicin—bone cancer	0.000659	0.00697	CcSEcCtD
Melatonin—Hepatic enzyme increased—Methotrexate—bone cancer	0.000652	0.0069	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Epirubicin—bone cancer	0.000635	0.00671	CcSEcCtD
Melatonin—Hypocalcaemia—Epirubicin—bone cancer	0.00063	0.00667	CcSEcCtD
Melatonin—Lacrimation increased—Epirubicin—bone cancer	0.000626	0.00662	CcSEcCtD
Melatonin—Nocturia—Epirubicin—bone cancer	0.000622	0.00658	CcSEcCtD
Melatonin—Stomatitis—Cisplatin—bone cancer	0.000613	0.00648	CcSEcCtD
Melatonin—MPO—connective tissue—bone cancer	0.000606	0.0236	CbGeAlD
Melatonin—Hepatobiliary disease—Cisplatin—bone cancer	0.000595	0.00629	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.000587	0.00621	CcSEcCtD
Melatonin—Neck pain—Epirubicin—bone cancer	0.000584	0.00618	CcSEcCtD
Melatonin—Hypocalcaemia—Doxorubicin—bone cancer	0.000583	0.00617	CcSEcCtD
Melatonin—Lacrimation increased—Doxorubicin—bone cancer	0.00058	0.00613	CcSEcCtD
Melatonin—Nocturia—Doxorubicin—bone cancer	0.000576	0.00609	CcSEcCtD
Melatonin—Abnormal dreams—Epirubicin—bone cancer	0.00057	0.00603	CcSEcCtD
Melatonin—Salivary hypersecretion—Epirubicin—bone cancer	0.000561	0.00593	CcSEcCtD
Melatonin—Mouth ulceration—Methotrexate—bone cancer	0.000558	0.0059	CcSEcCtD
Melatonin—Urine output increased—Methotrexate—bone cancer	0.000558	0.0059	CcSEcCtD
Melatonin—Urinary tract disorder—Cisplatin—bone cancer	0.000557	0.0059	CcSEcCtD
Melatonin—Connective tissue disorder—Cisplatin—bone cancer	0.000555	0.00587	CcSEcCtD
Melatonin—Urethral disorder—Cisplatin—bone cancer	0.000553	0.00585	CcSEcCtD
Melatonin—NQO2—tendon—bone cancer	0.000541	0.0211	CbGeAlD
Melatonin—Neck pain—Doxorubicin—bone cancer	0.000541	0.00572	CcSEcCtD
Melatonin—Abnormal dreams—Doxorubicin—bone cancer	0.000528	0.00558	CcSEcCtD
Melatonin—Eye disorder—Cisplatin—bone cancer	0.000527	0.00558	CcSEcCtD
Melatonin—NQO2—bone marrow—bone cancer	0.000524	0.0204	CbGeAlD
Melatonin—Cardiac disorder—Cisplatin—bone cancer	0.000524	0.00554	CcSEcCtD
Melatonin—NQO2—spinal cord—bone cancer	0.000522	0.0203	CbGeAlD
Melatonin—Mouth ulceration—Epirubicin—bone cancer	0.000522	0.00552	CcSEcCtD
Melatonin—Salivary hypersecretion—Doxorubicin—bone cancer	0.000519	0.00549	CcSEcCtD
Melatonin—Polyuria—Methotrexate—bone cancer	0.00051	0.00539	CcSEcCtD
Melatonin—Immune system disorder—Cisplatin—bone cancer	0.00051	0.00539	CcSEcCtD
Melatonin—CYP19A1—connective tissue—bone cancer	0.000495	0.0193	CbGeAlD
Melatonin—Malnutrition—Cisplatin—bone cancer	0.000491	0.0052	CcSEcCtD
Melatonin—Erythema—Cisplatin—bone cancer	0.000491	0.0052	CcSEcCtD
Melatonin—Flatulence—Cisplatin—bone cancer	0.000484	0.00512	CcSEcCtD
Melatonin—Mouth ulceration—Doxorubicin—bone cancer	0.000483	0.00511	CcSEcCtD
Melatonin—Muscle spasms—Cisplatin—bone cancer	0.000472	0.005	CcSEcCtD
Melatonin—Eczema—Epirubicin—bone cancer	0.000466	0.00493	CcSEcCtD
Melatonin—Vision blurred—Cisplatin—bone cancer	0.000463	0.0049	CcSEcCtD
Melatonin—CYP1B1—connective tissue—bone cancer	0.000463	0.018	CbGeAlD
Melatonin—Lethargy—Methotrexate—bone cancer	0.000457	0.00483	CcSEcCtD
Melatonin—Hot flush—Epirubicin—bone cancer	0.000448	0.00474	CcSEcCtD
Melatonin—Menopausal symptoms—Epirubicin—bone cancer	0.000444	0.0047	CcSEcCtD
Melatonin—Leukopenia—Cisplatin—bone cancer	0.00044	0.00465	CcSEcCtD
Melatonin—Eczema—Doxorubicin—bone cancer	0.000431	0.00456	CcSEcCtD
Melatonin—ESR1—connective tissue—bone cancer	0.00043	0.0168	CbGeAlD
Melatonin—CALM2—connective tissue—bone cancer	0.000428	0.0167	CbGeAlD
Melatonin—Lethargy—Epirubicin—bone cancer	0.000428	0.00452	CcSEcCtD
Melatonin—Irritability—Methotrexate—bone cancer	0.000427	0.00452	CcSEcCtD
Melatonin—CALM1—connective tissue—bone cancer	0.000426	0.0166	CbGeAlD
Melatonin—Mood swings—Methotrexate—bone cancer	0.000424	0.00449	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—bone cancer	0.000421	0.00445	CcSEcCtD
Melatonin—Pain in extremity—Epirubicin—bone cancer	0.000419	0.00443	CcSEcCtD
Melatonin—Anxiety—Cisplatin—bone cancer	0.000417	0.00441	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000415	0.00439	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—bone cancer	0.000414	0.00438	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—bone cancer	0.000413	0.00437	CcSEcCtD
Melatonin—Affect lability—Epirubicin—bone cancer	0.000412	0.00436	CcSEcCtD
Melatonin—Migraine—Epirubicin—bone cancer	0.000412	0.00436	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—bone cancer	0.000411	0.00435	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—bone cancer	0.000405	0.00428	CcSEcCtD
Melatonin—MPO—bone marrow—bone cancer	0.000404	0.0157	CbGeAlD
Melatonin—MPO—spinal cord—bone cancer	0.000402	0.0157	CbGeAlD
Melatonin—Infection—Cisplatin—bone cancer	0.000398	0.00421	CcSEcCtD
Melatonin—Mood swings—Epirubicin—bone cancer	0.000397	0.0042	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—bone cancer	0.000396	0.00418	CcSEcCtD
Melatonin—Nervous system disorder—Cisplatin—bone cancer	0.000393	0.00416	CcSEcCtD
Melatonin—Thrombocytopenia—Cisplatin—bone cancer	0.000393	0.00415	CcSEcCtD
Melatonin—Skin disorder—Cisplatin—bone cancer	0.00039	0.00412	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—bone cancer	0.000389	0.00412	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—bone cancer	0.000388	0.0041	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—bone cancer	0.000387	0.00409	CcSEcCtD
Melatonin—Dry skin—Epirubicin—bone cancer	0.000384	0.00406	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—bone cancer	0.000383	0.00405	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—bone cancer	0.000382	0.00404	CcSEcCtD
Melatonin—Migraine—Doxorubicin—bone cancer	0.000382	0.00404	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—bone cancer	0.000379	0.004	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—bone cancer	0.000375	0.00396	CcSEcCtD
Melatonin—CALM3—tendon—bone cancer	0.000374	0.0146	CbGeAlD
Melatonin—Abdominal discomfort—Methotrexate—bone cancer	0.000371	0.00392	CcSEcCtD
Melatonin—Gastritis—Epirubicin—bone cancer	0.000371	0.00392	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—bone cancer	0.000367	0.00388	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000365	0.00386	CcSEcCtD
Melatonin—CALM3—bone marrow—bone cancer	0.000363	0.0141	CbGeAlD
Melatonin—CALM3—spinal cord—bone cancer	0.000361	0.0141	CbGeAlD
Melatonin—Paraesthesia—Cisplatin—bone cancer	0.00036	0.00381	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—bone cancer	0.000358	0.00379	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—bone cancer	0.000355	0.00376	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—bone cancer	0.000354	0.00375	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—bone cancer	0.000353	0.00373	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—bone cancer	0.00035	0.00371	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—bone cancer	0.000347	0.00367	CcSEcCtD
Melatonin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000346	0.00366	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—bone cancer	0.000345	0.00365	CcSEcCtD
Melatonin—Infestation—Methotrexate—bone cancer	0.000345	0.00365	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—bone cancer	0.000343	0.00363	CcSEcCtD
Melatonin—Pain—Cisplatin—bone cancer	0.000343	0.00363	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—bone cancer	0.000336	0.00356	CcSEcCtD
Melatonin—Weight increased—Epirubicin—bone cancer	0.00033	0.00349	CcSEcCtD
Melatonin—Haematuria—Methotrexate—bone cancer	0.000329	0.00348	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—bone cancer	0.000326	0.00345	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—bone cancer	0.000326	0.00345	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—bone cancer	0.000323	0.00342	CcSEcCtD
Melatonin—Infestation—Epirubicin—bone cancer	0.000323	0.00342	CcSEcCtD
Melatonin—CYP1B1—tendon—bone cancer	0.000318	0.0124	CbGeAlD
Melatonin—Stomatitis—Epirubicin—bone cancer	0.000315	0.00333	CcSEcCtD
Melatonin—Haematuria—Epirubicin—bone cancer	0.000308	0.00326	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—bone cancer	0.000306	0.00324	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—bone cancer	0.000305	0.00323	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—bone cancer	0.000305	0.00323	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—bone cancer	0.000304	0.00321	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—bone cancer	0.000299	0.00316	CcSEcCtD
Melatonin—Infestation—Doxorubicin—bone cancer	0.000299	0.00316	CcSEcCtD
Melatonin—Hypersensitivity—Cisplatin—bone cancer	0.000295	0.00312	CcSEcCtD
Melatonin—CALM2—tendon—bone cancer	0.000294	0.0115	CbGeAlD
Melatonin—CALM1—tendon—bone cancer	0.000293	0.0114	CbGeAlD
Melatonin—Stomatitis—Doxorubicin—bone cancer	0.000291	0.00308	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—bone cancer	0.000289	0.00306	CcSEcCtD
Melatonin—Asthenia—Cisplatin—bone cancer	0.000288	0.00304	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—bone cancer	0.000287	0.00304	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—bone cancer	0.000286	0.00303	CcSEcCtD
Melatonin—CALM2—bone marrow—bone cancer	0.000285	0.0111	CbGeAlD
Melatonin—Haematuria—Doxorubicin—bone cancer	0.000285	0.00301	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—bone cancer	0.000285	0.00301	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—bone cancer	0.000284	0.00301	CcSEcCtD
Melatonin—CALM2—spinal cord—bone cancer	0.000284	0.0111	CbGeAlD
Melatonin—CALM1—bone marrow—bone cancer	0.000284	0.011	CbGeAlD
Melatonin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000283	0.00299	CcSEcCtD
Melatonin—CALM1—spinal cord—bone cancer	0.000282	0.011	CbGeAlD
Melatonin—Angiopathy—Methotrexate—bone cancer	0.000281	0.00297	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—bone cancer	0.00028	0.00296	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—bone cancer	0.000271	0.00287	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—bone cancer	0.000271	0.00287	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—bone cancer	0.00027	0.00285	CcSEcCtD
Melatonin—Erythema—Methotrexate—bone cancer	0.00027	0.00285	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—bone cancer	0.000269	0.00285	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—bone cancer	0.000265	0.0028	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—bone cancer	0.000264	0.00279	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—bone cancer	0.000263	0.00278	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—bone cancer	0.000263	0.00278	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—bone cancer	0.000262	0.00277	CcSEcCtD
Melatonin—Back pain—Methotrexate—bone cancer	0.000261	0.00276	CcSEcCtD
Melatonin—Vomiting—Cisplatin—bone cancer	0.000255	0.0027	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—bone cancer	0.000254	0.00269	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—bone cancer	0.000254	0.00269	CcSEcCtD
Melatonin—Rash—Cisplatin—bone cancer	0.000253	0.00267	CcSEcCtD
Melatonin—Dermatitis—Cisplatin—bone cancer	0.000253	0.00267	CcSEcCtD
Melatonin—Erythema—Epirubicin—bone cancer	0.000252	0.00267	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—bone cancer	0.000252	0.00267	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—bone cancer	0.000251	0.00265	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—bone cancer	0.000249	0.00263	CcSEcCtD
Melatonin—Flatulence—Epirubicin—bone cancer	0.000249	0.00263	CcSEcCtD
Melatonin—Tension—Epirubicin—bone cancer	0.000248	0.00262	CcSEcCtD
Melatonin—Nervousness—Epirubicin—bone cancer	0.000245	0.00259	CcSEcCtD
Melatonin—Back pain—Epirubicin—bone cancer	0.000244	0.00258	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—bone cancer	0.000243	0.00257	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—bone cancer	0.000243	0.00257	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—bone cancer	0.000242	0.00256	CcSEcCtD
Melatonin—Vertigo—Methotrexate—bone cancer	0.000242	0.00256	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—bone cancer	0.000241	0.00255	CcSEcCtD
Melatonin—Nausea—Cisplatin—bone cancer	0.000238	0.00252	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—bone cancer	0.000238	0.00252	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—bone cancer	0.000235	0.00249	CcSEcCtD
Melatonin—Erythema—Doxorubicin—bone cancer	0.000233	0.00247	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—bone cancer	0.000233	0.00247	CcSEcCtD
Melatonin—Agitation—Epirubicin—bone cancer	0.000232	0.00245	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—bone cancer	0.00023	0.00243	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—bone cancer	0.00023	0.00243	CcSEcCtD
Melatonin—Chest pain—Methotrexate—bone cancer	0.00023	0.00243	CcSEcCtD
Melatonin—Tension—Doxorubicin—bone cancer	0.000229	0.00242	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000228	0.00241	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—bone cancer	0.000227	0.0024	CcSEcCtD
Melatonin—Vertigo—Epirubicin—bone cancer	0.000227	0.0024	CcSEcCtD
Melatonin—Syncope—Epirubicin—bone cancer	0.000226	0.00239	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—bone cancer	0.000226	0.00239	CcSEcCtD
Melatonin—Back pain—Doxorubicin—bone cancer	0.000226	0.00239	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—bone cancer	0.000224	0.00237	CcSEcCtD
Melatonin—Palpitations—Epirubicin—bone cancer	0.000223	0.00236	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—bone cancer	0.000222	0.00235	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—bone cancer	0.00022	0.00233	CcSEcCtD
Melatonin—Infection—Methotrexate—bone cancer	0.000219	0.00231	CcSEcCtD
Melatonin—Hypertension—Epirubicin—bone cancer	0.000218	0.0023	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—bone cancer	0.000216	0.00228	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—bone cancer	0.000215	0.00228	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—bone cancer	0.000215	0.00227	CcSEcCtD
Melatonin—Chest pain—Epirubicin—bone cancer	0.000215	0.00227	CcSEcCtD
Melatonin—Agitation—Doxorubicin—bone cancer	0.000215	0.00227	CcSEcCtD
Melatonin—Anxiety—Epirubicin—bone cancer	0.000214	0.00226	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—bone cancer	0.000214	0.00226	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000213	0.00226	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—bone cancer	0.00021	0.00222	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—bone cancer	0.00021	0.00222	CcSEcCtD
Melatonin—Syncope—Doxorubicin—bone cancer	0.000209	0.00221	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—bone cancer	0.000209	0.00221	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—bone cancer	0.000206	0.00218	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—bone cancer	0.000205	0.00217	CcSEcCtD
Melatonin—Infection—Epirubicin—bone cancer	0.000205	0.00216	CcSEcCtD
Melatonin—Shock—Epirubicin—bone cancer	0.000203	0.00214	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—bone cancer	0.000202	0.00214	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—bone cancer	0.000202	0.00213	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—bone cancer	0.000202	0.00213	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.0002	0.00212	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—bone cancer	0.0002	0.00212	CcSEcCtD
Melatonin—Insomnia—Methotrexate—bone cancer	0.000199	0.00211	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—bone cancer	0.000199	0.0021	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—bone cancer	0.000199	0.0021	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—bone cancer	0.000198	0.0021	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—bone cancer	0.000198	0.00209	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000197	0.00209	CcSEcCtD
Melatonin—Somnolence—Methotrexate—bone cancer	0.000196	0.00207	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—bone cancer	0.000194	0.00206	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—bone cancer	0.000194	0.00205	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00019	0.00201	CcSEcCtD
Melatonin—Fatigue—Methotrexate—bone cancer	0.00019	0.00201	CcSEcCtD
Melatonin—Infection—Doxorubicin—bone cancer	0.000189	0.002	CcSEcCtD
Melatonin—Pain—Methotrexate—bone cancer	0.000188	0.00199	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000188	0.00198	CcSEcCtD
Melatonin—Shock—Doxorubicin—bone cancer	0.000187	0.00198	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—bone cancer	0.000187	0.00198	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—bone cancer	0.000187	0.00197	CcSEcCtD
Melatonin—Insomnia—Epirubicin—bone cancer	0.000186	0.00197	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—bone cancer	0.000185	0.00196	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—bone cancer	0.000185	0.00196	CcSEcCtD
Melatonin—Somnolence—Epirubicin—bone cancer	0.000183	0.00194	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—bone cancer	0.000181	0.00192	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—bone cancer	0.00018	0.0019	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000178	0.00188	CcSEcCtD
Melatonin—Fatigue—Epirubicin—bone cancer	0.000178	0.00188	CcSEcCtD
Melatonin—Pain—Epirubicin—bone cancer	0.000176	0.00186	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—bone cancer	0.000174	0.00184	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000174	0.00184	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—bone cancer	0.000172	0.00182	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—bone cancer	0.000171	0.00181	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—bone cancer	0.000169	0.00179	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—bone cancer	0.000168	0.00178	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—bone cancer	0.000168	0.00177	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000164	0.00174	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—bone cancer	0.000164	0.00174	CcSEcCtD
Melatonin—Pain—Doxorubicin—bone cancer	0.000163	0.00172	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—bone cancer	0.000163	0.00172	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—bone cancer	0.000162	0.00171	CcSEcCtD
Melatonin—Asthenia—Methotrexate—bone cancer	0.000158	0.00167	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000156	0.00165	CcSEcCtD
Melatonin—Pruritus—Methotrexate—bone cancer	0.000156	0.00165	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—bone cancer	0.000152	0.0016	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—bone cancer	0.000151	0.00159	CcSEcCtD
Melatonin—Asthenia—Epirubicin—bone cancer	0.000148	0.00156	CcSEcCtD
Melatonin—Pruritus—Epirubicin—bone cancer	0.000146	0.00154	CcSEcCtD
Melatonin—Dizziness—Methotrexate—bone cancer	0.000146	0.00154	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—bone cancer	0.00014	0.00148	CcSEcCtD
Melatonin—Vomiting—Methotrexate—bone cancer	0.00014	0.00148	CcSEcCtD
Melatonin—Rash—Methotrexate—bone cancer	0.000139	0.00147	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—bone cancer	0.000139	0.00147	CcSEcCtD
Melatonin—Headache—Methotrexate—bone cancer	0.000138	0.00146	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—bone cancer	0.000137	0.00145	CcSEcCtD
Melatonin—Dizziness—Epirubicin—bone cancer	0.000136	0.00144	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—bone cancer	0.000135	0.00143	CcSEcCtD
Melatonin—Vomiting—Epirubicin—bone cancer	0.000131	0.00138	CcSEcCtD
Melatonin—Nausea—Methotrexate—bone cancer	0.000131	0.00138	CcSEcCtD
Melatonin—Rash—Epirubicin—bone cancer	0.00013	0.00137	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—bone cancer	0.00013	0.00137	CcSEcCtD
Melatonin—Headache—Epirubicin—bone cancer	0.000129	0.00136	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—bone cancer	0.000126	0.00133	CcSEcCtD
Melatonin—Nausea—Epirubicin—bone cancer	0.000122	0.00129	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—bone cancer	0.000121	0.00128	CcSEcCtD
Melatonin—Rash—Doxorubicin—bone cancer	0.00012	0.00127	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—bone cancer	0.00012	0.00127	CcSEcCtD
Melatonin—Headache—Doxorubicin—bone cancer	0.000119	0.00126	CcSEcCtD
Melatonin—Nausea—Doxorubicin—bone cancer	0.000113	0.0012	CcSEcCtD
Melatonin—CYP19A1—Metabolism—DHFR—bone cancer	4.24e-05	0.0002	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—EGFR—bone cancer	4.2e-05	0.000199	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—EGFR—bone cancer	4.2e-05	0.000199	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—EGFR—bone cancer	4.18e-05	0.000198	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—EGFR—bone cancer	4.18e-05	0.000198	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—EGFR—bone cancer	4.16e-05	0.000197	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—EGFR—bone cancer	4.16e-05	0.000197	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—EGFR—bone cancer	4.14e-05	0.000196	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—EGFR—bone cancer	4.14e-05	0.000196	CbGpPWpGaD
Melatonin—CALM3—Neuronal System—MDM2—bone cancer	4.1e-05	0.000194	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—DHFR—bone cancer	4.08e-05	0.000193	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	4.03e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—EGFR—bone cancer	4.03e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—EGFR—bone cancer	4.03e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—MDM2—bone cancer	4.02e-05	0.00019	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—JUN—bone cancer	3.99e-05	0.000189	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—JUN—bone cancer	3.99e-05	0.000189	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—EGFR—bone cancer	3.99e-05	0.000189	CbGpPWpGaD
Melatonin—CALM2—Neuronal System—MDM2—bone cancer	3.96e-05	0.000187	CbGpPWpGaD
Melatonin—CALM1—Neuronal System—MDM2—bone cancer	3.96e-05	0.000187	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—GNA11—bone cancer	3.96e-05	0.000187	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—EGFR—bone cancer	3.96e-05	0.000187	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NT5C3A—bone cancer	3.94e-05	0.000187	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—EGFR—bone cancer	3.94e-05	0.000186	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—EGFR—bone cancer	3.9e-05	0.000184	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—MMP9—bone cancer	3.89e-05	0.000184	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—MMP9—bone cancer	3.89e-05	0.000184	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—MDM2—bone cancer	3.89e-05	0.000184	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—MDM2—bone cancer	3.89e-05	0.000184	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—EGFR—bone cancer	3.86e-05	0.000183	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—EGFR—bone cancer	3.86e-05	0.000183	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—SMO—bone cancer	3.83e-05	0.000181	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—EGFR—bone cancer	3.83e-05	0.000181	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—EGFR—bone cancer	3.83e-05	0.000181	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—GNA11—bone cancer	3.81e-05	0.00018	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—EGFR—bone cancer	3.81e-05	0.00018	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—EGFR—bone cancer	3.81e-05	0.00018	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—EGFR—bone cancer	3.73e-05	0.000176	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—SMO—bone cancer	3.71e-05	0.000175	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—SMO—bone cancer	3.71e-05	0.000175	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RGS1—bone cancer	3.71e-05	0.000175	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GRM4—bone cancer	3.71e-05	0.000175	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—PLAU—bone cancer	3.63e-05	0.000172	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—EGFR—bone cancer	3.61e-05	0.000171	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—EGFR—bone cancer	3.61e-05	0.000171	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—CYP3A4—bone cancer	3.59e-05	0.00017	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RGS1—bone cancer	3.58e-05	0.000169	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RGS1—bone cancer	3.58e-05	0.000169	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GRM4—bone cancer	3.58e-05	0.000169	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GRM4—bone cancer	3.58e-05	0.000169	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.57e-05	0.000169	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	3.57e-05	0.000169	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—PLAU—bone cancer	3.51e-05	0.000166	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—PLAU—bone cancer	3.51e-05	0.000166	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—GNA11—bone cancer	3.5e-05	0.000166	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—CYP3A4—bone cancer	3.46e-05	0.000164	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	3.45e-05	0.000163	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	3.45e-05	0.000163	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.44e-05	0.000163	CbGpPWpGaD
Melatonin—CALM3—Disease—ENO2—bone cancer	3.41e-05	0.000161	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—GNA11—bone cancer	3.39e-05	0.00016	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—GNA11—bone cancer	3.39e-05	0.00016	CbGpPWpGaD
Melatonin—CALM2—Disease—ENO2—bone cancer	3.3e-05	0.000156	CbGpPWpGaD
Melatonin—CALM1—Disease—ENO2—bone cancer	3.3e-05	0.000156	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SMO—bone cancer	3.24e-05	0.000153	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GRM1—bone cancer	3.21e-05	0.000152	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL3—bone cancer	3.18e-05	0.00015	CbGpPWpGaD
Melatonin—CALM3—Disease—DHFR—bone cancer	3.16e-05	0.00015	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—EGFR—bone cancer	3.14e-05	0.000148	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—EGFR—bone cancer	3.14e-05	0.000148	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GRM1—bone cancer	3.11e-05	0.000147	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GRM1—bone cancer	3.11e-05	0.000147	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL3—bone cancer	3.07e-05	0.000145	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL3—bone cancer	3.07e-05	0.000145	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—GSTP1—bone cancer	3.07e-05	0.000145	CbGpPWpGaD
Melatonin—CALM1—Disease—DHFR—bone cancer	3.06e-05	0.000145	CbGpPWpGaD
Melatonin—CALM2—Disease—DHFR—bone cancer	3.06e-05	0.000145	CbGpPWpGaD
Melatonin—CALM3—Immune System—ATF1—bone cancer	2.98e-05	0.000141	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—GNA11—bone cancer	2.97e-05	0.00014	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—GSTP1—bone cancer	2.96e-05	0.00014	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KIT—bone cancer	2.91e-05	0.000138	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL3—bone cancer	2.9e-05	0.000137	CbGpPWpGaD
Melatonin—CALM2—Immune System—ATF1—bone cancer	2.88e-05	0.000136	CbGpPWpGaD
Melatonin—CALM1—Immune System—ATF1—bone cancer	2.88e-05	0.000136	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ENO2—bone cancer	2.86e-05	0.000135	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KIT—bone cancer	2.81e-05	0.000133	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KIT—bone cancer	2.81e-05	0.000133	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL3—bone cancer	2.81e-05	0.000133	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL3—bone cancer	2.81e-05	0.000133	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KIT—bone cancer	2.79e-05	0.000132	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ENO2—bone cancer	2.76e-05	0.000131	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ENO2—bone cancer	2.76e-05	0.000131	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ATF1—bone cancer	2.76e-05	0.00013	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—EGFR—bone cancer	2.74e-05	0.00013	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ENO2—bone cancer	2.71e-05	0.000128	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KIT—bone cancer	2.7e-05	0.000128	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KIT—bone cancer	2.7e-05	0.000128	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL3—bone cancer	2.69e-05	0.000127	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—EGFR—bone cancer	2.66e-05	0.000126	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—EGFR—bone cancer	2.66e-05	0.000126	CbGpPWpGaD
Melatonin—CALM3—Metabolism—DHFR—bone cancer	2.65e-05	0.000125	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—bone cancer	2.64e-05	0.000125	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—bone cancer	2.64e-05	0.000125	CbGpPWpGaD
Melatonin—CALM2—Metabolism—DHFR—bone cancer	2.56e-05	0.000121	CbGpPWpGaD
Melatonin—CALM1—Metabolism—DHFR—bone cancer	2.56e-05	0.000121	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—DHFR—bone cancer	2.51e-05	0.000119	CbGpPWpGaD
Melatonin—CALM3—Metabolism—GNA11—bone cancer	2.48e-05	0.000117	CbGpPWpGaD
Melatonin—CALM2—Metabolism—GNA11—bone cancer	2.39e-05	0.000113	CbGpPWpGaD
Melatonin—CALM1—Metabolism—GNA11—bone cancer	2.39e-05	0.000113	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—GNA11—bone cancer	2.35e-05	0.000111	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFBR2—bone cancer	2.3e-05	0.000109	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFBR2—bone cancer	2.29e-05	0.000108	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—MDM2—bone cancer	2.29e-05	0.000108	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMO—bone cancer	2.26e-05	0.000107	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CYP3A4—bone cancer	2.24e-05	0.000106	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFBR2—bone cancer	2.22e-05	0.000105	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFBR2—bone cancer	2.22e-05	0.000105	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ENO2—bone cancer	2.22e-05	0.000105	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—MDM2—bone cancer	2.22e-05	0.000105	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—MDM2—bone cancer	2.22e-05	0.000105	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—MDM2—bone cancer	2.2e-05	0.000104	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMO—bone cancer	2.19e-05	0.000104	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMO—bone cancer	2.19e-05	0.000104	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CYP3A4—bone cancer	2.17e-05	0.000103	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CYP3A4—bone cancer	2.17e-05	0.000103	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IGF1R—bone cancer	2.16e-05	0.000102	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000101	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—MDM2—bone cancer	2.13e-05	0.000101	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—MDM2—bone cancer	2.13e-05	0.000101	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.12e-05	0.0001	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GNA11—bone cancer	2.07e-05	9.79e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—DHFR—bone cancer	2.06e-05	9.73e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO2—bone cancer	2.02e-05	9.56e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GNA11—bone cancer	2e-05	9.47e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GNA11—bone cancer	2e-05	9.47e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—JUN—bone cancer	1.99e-05	9.42e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—JUN—bone cancer	1.93e-05	9.11e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—JUN—bone cancer	1.93e-05	9.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ATF1—bone cancer	1.92e-05	9.1e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GNA11—bone cancer	1.92e-05	9.09e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—GSTP1—bone cancer	1.92e-05	9.08e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL3—bone cancer	1.88e-05	8.88e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—DHFR—bone cancer	1.88e-05	8.87e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ATF1—bone cancer	1.86e-05	8.8e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ATF1—bone cancer	1.86e-05	8.8e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—GSTP1—bone cancer	1.86e-05	8.78e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—GSTP1—bone cancer	1.86e-05	8.78e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—GSTP1—bone cancer	1.82e-05	8.61e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL3—bone cancer	1.82e-05	8.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL3—bone cancer	1.82e-05	8.59e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GNA11—bone cancer	1.75e-05	8.29e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP3A4—bone cancer	1.74e-05	8.24e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	8.2e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO2—bone cancer	1.73e-05	8.17e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KIT—bone cancer	1.69e-05	8.01e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KIT—bone cancer	1.64e-05	7.75e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KIT—bone cancer	1.64e-05	7.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFBR2—bone cancer	1.61e-05	7.59e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—DHFR—bone cancer	1.6e-05	7.58e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—bone cancer	1.59e-05	7.52e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.59e-05	7.51e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.58e-05	7.48e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KIT—bone cancer	1.57e-05	7.42e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—EGFR—bone cancer	1.57e-05	7.4e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KIT—bone cancer	1.56e-05	7.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFBR2—bone cancer	1.55e-05	7.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFBR2—bone cancer	1.55e-05	7.34e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—bone cancer	1.53e-05	7.25e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—EGFR—bone cancer	1.51e-05	7.16e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—EGFR—bone cancer	1.51e-05	7.16e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KIT—bone cancer	1.51e-05	7.15e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KIT—bone cancer	1.51e-05	7.15e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1R—bone cancer	1.51e-05	7.14e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—EGFR—bone cancer	1.5e-05	7.11e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GNA11—bone cancer	1.5e-05	7.08e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GSTP1—bone cancer	1.49e-05	7.05e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—BRAF—bone cancer	1.47e-05	6.97e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—BRAF—bone cancer	1.47e-05	6.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1R—bone cancer	1.46e-05	6.91e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1R—bone cancer	1.46e-05	6.91e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—bone cancer	1.46e-05	6.9e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—EGFR—bone cancer	1.45e-05	6.88e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—EGFR—bone cancer	1.45e-05	6.88e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—BRAF—bone cancer	1.42e-05	6.73e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—BRAF—bone cancer	1.42e-05	6.73e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—bone cancer	1.41e-05	6.68e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—bone cancer	1.41e-05	6.68e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSTP1—bone cancer	1.36e-05	6.43e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.36e-05	6.42e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.35e-05	6.39e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MDM2—bone cancer	1.33e-05	6.31e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MDM2—bone cancer	1.29e-05	6.1e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MDM2—bone cancer	1.29e-05	6.1e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MDM2—bone cancer	1.24e-05	5.84e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MDM2—bone cancer	1.23e-05	5.83e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MDM2—bone cancer	1.19e-05	5.63e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MDM2—bone cancer	1.19e-05	5.63e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—bone cancer	1.19e-05	5.62e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTP1—bone cancer	1.16e-05	5.49e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—JUN—bone cancer	1.16e-05	5.48e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—bone cancer	1.15e-05	5.43e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—bone cancer	1.15e-05	5.43e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—JUN—bone cancer	1.12e-05	5.3e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—JUN—bone cancer	1.12e-05	5.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIT—bone cancer	1.1e-05	5.18e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—JUN—bone cancer	1.07e-05	5.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIT—bone cancer	1.06e-05	5.01e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIT—bone cancer	1.06e-05	5.01e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—bone cancer	1.04e-05	4.94e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—BRAF—bone cancer	1.03e-05	4.87e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—bone cancer	9.98e-06	4.72e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—bone cancer	9.96e-06	4.71e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—bone cancer	9.96e-06	4.71e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—bone cancer	9.95e-06	4.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—bone cancer	9.65e-06	4.56e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—bone cancer	9.65e-06	4.56e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—bone cancer	9.62e-06	4.55e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—bone cancer	9.62e-06	4.55e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—bone cancer	9.44e-06	4.46e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—bone cancer	9.12e-06	4.31e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—bone cancer	8.82e-06	4.17e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—bone cancer	8.82e-06	4.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—bone cancer	8.63e-06	4.08e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—bone cancer	8.44e-06	3.99e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—bone cancer	8.42e-06	3.98e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—bone cancer	8.34e-06	3.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—bone cancer	8.34e-06	3.95e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—bone cancer	8.14e-06	3.85e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—bone cancer	8.14e-06	3.85e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—bone cancer	7.72e-06	3.65e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—bone cancer	7.5e-06	3.55e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—bone cancer	7.29e-06	3.45e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—bone cancer	7.25e-06	3.43e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—bone cancer	7.25e-06	3.43e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—bone cancer	7.09e-06	3.35e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—bone cancer	7.06e-06	3.34e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—bone cancer	7.06e-06	3.34e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—bone cancer	7.04e-06	3.33e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—bone cancer	6.02e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—bone cancer	5.89e-06	2.79e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—bone cancer	5.7e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—bone cancer	5.7e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—bone cancer	4.95e-06	2.34e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—bone cancer	4.79e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—bone cancer	4.79e-06	2.26e-05	CbGpPWpGaD
